Used in pharmaceutical research as a key intermediate in the synthesis of serotonin receptor modulators, particularly 5-HT1A ligands, which are investigated for their potential in treating neurological and psychiatric disorders such as anxiety, depression, and schizophrenia. Its structure allows for selective binding and functional activity in central nervous system targets. Also explored in the development of imaging agents for neuroreceptor mapping.